000590 Tus-Pharmaceutical Group

Watchlist

7.22
-0.21-2.83%

Not Open Dec 30 15:00 CST

1.73BMarket Cap-180.50P/E (TTM)

Tus-Pharmaceutical Group Key Stats

According to the latest financial report of Tus-Pharmaceutical Group, the latest earnings per share (TTM) for the company is -0.12. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

BVPS

Analyzing a company's fundamentals? Check out Tus-Pharmaceutical Group's latest financial report to see how much their book value per share (BVPS) is currently at 2.90.

Currency: CNY

Cumulative Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Tus-Pharmaceutical Group shows that the company's current ratio is 2.22, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Tus-Pharmaceutical Group, the quick ratio is 1.55, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

ROE

Want to learn more about the financial health of Tus-Pharmaceutical Group? The latest ROE figure is -4.01%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Tus-Pharmaceutical Group, the total asset return on investment (ROA) is -2.50%.

Currency: CNY

Cumulative Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Tus-Pharmaceutical Group's latest financial report to see how their gross margin is doing - currently at 46.21%.

Currency: CNY

Cumulative Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Tus-Pharmaceutical Group, the net profit margin is -13.06%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Symbol Price % Chg

Flaircomm Microelectronics, Inc.